Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Informed consent~* Age: 19-60 year-old women~* Plan of myomectomy for uterine leiomyomas~* Leiomyoma Subclassification System 2-7 (robot-assisted laparoscopic myomectomy is possible)~* American Society of Anesthesiologists Physical Status classification 1 or 2~* A person who understands the contents of the clinical trial, is cooperative with the trial, and is judged to be able to participate until the end of the study~Exclusion Criteria:~* Pregnancy or breastfeeding~* A single diameter of uterine leiomyoma is greater than 12 cm or more or multiple leiomyomas with more than five~* Suspicious disease of uterine malignancy~* Patient with has a history of pelvic surgery (cesarean section, myomectomy, etc.) and is expected to have severe pelvic adhesion~* A person who is hypersensitive or contraindicated to vasopressin~* A person who is hypersensitive or contraindicated to tranexamic acid~* Considered as inappropriate by the researcher's judgment

- Gender: FEMALE
- Minimum Age: 19 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Diluted Vasopressin Group 1 (Type: ACTIVE_COMPARATOR): During robot-assisted laparoscopic myomectomy, diluted vasopressin (a solution prepared by mixing 20 units of vasopressin with 50 ml of normal saline to make a total of 100 ml) was injected before uterine serosal incision.
- Diluted Vasopressin Group 2 (Type: ACTIVE_COMPARATOR): During robot-assisted laparoscopic myomectomy, diluted vasopressin (a solution prepared by mixing 20 units of vasopressin with 200 ml of normal saline to make a total of 100 m) was injected before uterine serosal incision.
- Diluted Vasopressin Group 3 (Type: ACTIVE_COMPARATOR): During robot-assisted laparoscopic myomectomy, diluted vasopressin (a solution prepared by mixing 20 units of vasopressin with 400 ml of normal saline to make a total of 100 m) was injected before uterine serosal incision.

Based on this trial design, predict the completion outcome and termination type (if applicable).